Pfizer/BioNTech: Comirnaty Bivalent Original/Omicron BA.1

Vaccine Type: RNA

This vaccine may also be referred to as BNT162b2 (B.1.1.529), BNT162b2 Bivalent (WT/OMI BA.1)

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 2 Trials

Phase 3: 1 Trial

Approvals

35 Countries

Registered Trials